Please login to the form below

Not currently logged in
Email:
Password:

Emas appoints Dr Neil Murray

He joins the UK-based contract research organisation as senior VP medicines development

UK-based contract research organisation Emas has appointed Dr Neil Murray as senior VP medicines development.

Dr Murray has over 22 years' experience in the pharmaceutical industry, during which time he most recently served as European medical director at Eisai Europe.

Prior to this he was head of clinical development at Ark Therapeutics and global head of pharmacovigilance at F.Hoffmann-La Roche.

In his new role at Emas Dr Murray will oversee clinical operations, regulatory affairs and drug safety.

18th November 2011

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Cuttsy + Cuttsy

How do you understand what patients really need, without actually living their lives? How do you walk in someone else’s...

Latest intelligence

Virtual Hackathon on Healthcare Innovation: a Customer Story
How participants from 9 different countries in the APAC region were brought together to participate in a pharmaceutical company-wide 3-day virtual "hackathon," with spectacular results....
OPEN Health at the World Orphan Drug Conference USA
Our Director of Rare Disease, Gavin Jones looks forward to his conversation with Emily Crossle & Betsy Bogard at #WODCUSA2020 !...
Can involving patients in design transform the clinical trial experience?
While the research space is a heavily regulated environment and there are rules that we must abide by, this doesn’t mean clinical study materials have to be ‘boring’ or the...

Infographics